Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872409 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusions: Thymidine phosphorylase expression or COX-2/TP coexpression may be used as a molecular prognostic marker for squamous cell carcinoma of the uterine cervix. TP appears to be an important downstream molecule of COX-2 during angiogenesis and may be a new target for the treatment of uterine cervical cancer.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hongryull M.D., Yong Bae M.D., Nam Hoon M.D., Chang Ok M.D., Tchan Kyu M.D., Yeon Sook Ph.D., Gwi Eon M.D.,